QIAGEN Advances Precision Medicine

Product News   Nov 18, 2017

 
QIAGEN Advances Precision Medicine
 
 
FURTHER INFORMATION
 
 
 

Related Product News

sphingotec is Adding an Advanced POC Testing Platform to Portfolio

Product News

POC testing of penKid® and bio-ADM® is set to add significant clinical benefit to emergency departments and intensive care units allowing on-site diagnosis, monitoring, and guidance in therapies of sepsis, decongestion in heart failure and acute kidney injury, thereby improving outcomes in acute heart failure, sepsis and other acute settings.

READ MORE

QIAGEN welcomes WHO’s Essential Diagnostics List which includes QuantiFERON-TB Gold

Product News

The World Health Organization recommends IGRA tests in the First Edition of Essential In Vitro Diagnostics.

READ MORE

Lonza Further Strengthens Hepatocytes Portfolio with Addition of Hepatic Non-Parenchymal Cells

Product News

Lonza has announced the addition of hepatic stellate cells, Kupffer cells and liver-derived endothelial cells to its extensive hepatocytes portfolio.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Genomics Research Informatics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE